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Introduction
Volatile anesthetics have been used to ensure surgical anesthesia 
for decades. While the instruments of anesthesia have improved a lot 
and anesthetic agents have become more and more secure during the 
past decades, occupational exposure and possible health damage to 
the operating personnel are still subjects of investigations and matter 
of debates nowadays. Most human data in this topic are based on 
epidemiological observations and are usually retrospective. On the 
one hand, prospective studies are limited due to ethical considerations 
and other coexisting factors with possible harmful effects (e.g. ionizing 
radiation, disinfectants, stress, etc.). Despite the fact that the presumed 
harmful effects of anesthetics are sometimes based on controversial 
observations, common sense should point toward caution and the 
determination of the most effective protective measures.
The present literature review aims to provide a comprehensive 
picture of the topic, summarizing the mechanisms how anesthetic 
gases leak into the operating room, the potential adverse health effects 
(particularly with regard to the low level of chronic exposure) and 
the technical opportunities that allow the effective recognition and 
quantification of leakage and contamination of the operating room’s 
air. A further, important issue is to resume the duties and safety 
measures that can radically reduce the degree of exposure. 
Inhalational Anesthesia and Halogenated Gases 
Despite the fact that total intravenous anesthesia has become more 
and more popular in recent years, halogenated gases are still preferred 
to maintain narcosis. In some cases, such as pediatric anesthesia, or 
when we are likely to face difficult intubation, inhalational anesthetic 
techniques are often chosen, in order to avoid respiratory depression.
During the development of anesthesia the spectrum of inhalational 
anesthetics has gradually changed. Currently sevoflurane, isoflurane, 
desflurane, enflurane and the less and less popular halothane are 
used as volatile anesthetics worldwide. Their extensive use can be 
explained with their favorable pharmacokinetic properties, predictable 
hemodynamic effects and tissue inert attributes. The colorlessness and 
highly volatile nature of halogenated anesthetics should be highlighted 
as common physical properties. When exposed into the air, these gases 
remain undetected to human senses in most cases, even in fairly high 
concentrations. For example, half of the population detected halothane 
in the first place only when its concentration in the air reached 250 
ppm, which is 125 folds higher than the maximum recommended level 
[1].
Possible Locations of Increased Anesthetic Exposition 
Typical locations where staff-members can be exposed to an 
increased level of inhalational anesthetics are well defined by the 
literature. These are the followings: 
• In operating rooms, where no air conditioning and/or air-suction 
devices are available. The extraction of volatile anesthetics and removal 
of mixed gases from surgical rooms into the outer environment is 
available in most of the operating theaters. In fact, however, such 
possibilities are not accessible, or little attention is paid in smaller, 
separate operating theaters (e.g. oral, dental surgery) and in veterinary 
operating rooms in particular, and thus an increased exposure should 
be expected.
• It might happen that although air suction and/or exchanger 
systems are attainable they do not work properly due to scanty 
inspection and maintenance.
• In post-anesthesia care units, where patients exhale a significant 
amount of anesthetic gas and the ventilation of the room is improper. 
Earlier no attention was paid during the design of most hospitals to 
install air-suction systems with suitable capacity in the awakening 
rooms. Therefore volatile gases could accumulate in such units.
• Lately an inhalation anesthetic-based sedation technique has 
become more and more widespread in ICU wards [such as AnaConDa® 
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system manufactured by Sedana Medical]. With this method it is 
theoretically possible that staff-members and other patients could 
be exposed to a certain amount of anesthetics, depending on the air 
conditioning and air suction circumstances of the ICU.
How can Anesthetic Gases Get into the Air of Operating 
Rooms? 
The most significant leakage occurs when the gas escapes 
somewhere between the airway securing instruments and the patient’s 
respiratory tract. Pediatric anesthesia with face masks, laryngeal masks 
or cuffless tracheal tubes significantly increase the concentration of 
anesthetic gases in the operating room [2,3]. In a recent study, Tankó 
et al. revealed that during intracerebral surgeries, the evaporated 
amount of sevoflurane is the highest at the anesthetist’s breathing zone, 
the most important source of this leakage is the patients’ mouth [4] 
and the amount of evaporated gas is independent of the endotracheal 
tube cuff pressure [5]. It has been also demonstrated that exposure 
of the anesthesia staff can be decreased by proper positioning of the 
anesthesia personnel during intracranial surgery [6].
The source of leakage could be any components of the anesthetic 
machine starting from the vaporizer, where hyper-atmospheric 
pressure prevails during mechanical ventilation. This section of the 
anesthetic machine involves the vaporizer, the common line, the limbs 
of the circuit, the Y-connector, the manual breathing bag - or ventilator 
bellows - and the CO2 absorber. Imperfect fitting between separate 
elements, an aperture in the worn out circuit or balloon may become 
a source of leakage immediately. Malfunctioning unidirectional valves 
could further increase the rate of leakage, due to the consequential 
increase in pressure. An additional source could also be the poor fitting 
of the capnograph’s sampling tube.
Adverse Health Effects of Anesthetic Gases
Observations on experimental animals 
Animal studies provide important data in order to understand the 
toxicology of inhalational gases and may help to reveal their hidden 
effects as well. These effects would otherwise develop very slowly under 
clinical circumstances, due to the chronic exposure to low concentration 
gases. The results of previous animal studies are summarized below:
Carcinogenesis: Numerous studies have been conducted in 
animals to test the possible carcinogenic effects of halothane, enflurane 
and isoflurane [7-9]. In these experiments, the exposure could have 
last for days or even a year, and in some cases the concentration could 
have exceeded multiple times the level of anesthetic gases realistically 
present in operating room. However, experiments with currently 
used anesthetic gases failed to prove malignant abnormalities from 
subsequently examined histological samples as a delayed consequence 
of the exposure. Sevoflurane and desflurane were approved without 
preliminary examinations, based on their relation to similar 
halogenated gases and the negative results of the previous studies. 
Therefore, no data in the literature is available relating to these agents.
Hepatotoxicity: It was proven that long-term exposure of 
halothane, isoflurane and enflurane in anesthetic concentrations 
may cause liver damage in mice, rats and guinea pigs, but such harm 
occurs mainly under special circumstances or adverse conditions 
(moderate hypoxia or significant malnutrition) [10-13]. However, 
toxicity is attributable to indirect noxae through metabolites that were 
biotransformed by the cytochrome P450. In contrast, no obvious organ 
damage was induced during months of sub-anesthetic exposition (10 
ppm halothane, 20 ppm or 200 ppm enflurane) [13,14]. No studies 
have registered organic lesions caused by the exposure to low or high 
concentrations of desflurane and sevoflurane.
Mutagenesis: Isoflurane, enflurane and halothane were tested on 
bacterial cells, mammalian cell cultures and experimental animals in 
order to detect their possible mutagenic effects [15-18]. The results of 
DNA analyses consistently suggest that the currently used anesthetics 
have no mutagenic effects.
Fertility: Gonads of female and male rats or mice were studied 
after several weeks of low and high concentrations of halogen exposure 
[halothane, enflurane and isoflurane]. Histological analyses were 
unable to detect results that would indicate impaired fertility in any 
cases [18-20].
Teratogenicity: Relatively few studies have examined the impact 
of halogenated inhalational agents on developmental abnormalities, 
especially when traceable concentrations of anesthetic were present. 
Experiments on female rats, exposed to 200 ppm enflurane 8 hours 
daily, five times a week, have shown no effect on the number of living 
fetuses, resorption, fetal weight, skeletal abnormalities, and the male/
female ratio of the litter [14]. Similar results were found when female 
mice have been exposed to 100-1000 ppm enflurane each day for 3 
weeks prior mating, during pregnancy or only between the 6th and 
15th gestational days [19]. When pregnant mice were exposed to 60, 
600 or 6000 ppm isoflurane for 4 hours daily, between the 6th and 
15th gestational days, decreased fetal weight gain and developmental 
anomalies were detected, but only with the highest isoflurane 
concentrations [21]. It has to be mentioned that the negative outcomes 
of these experiments were presumably not a result of direct gas effect, 
but a result of the long and rough physiological changes.
Human studies on sub-chronic and chronic effects of 
anesthetic gases 
Central nervous system: The first reports from the 70s on 
deteriorating psychomotoric performance of the operating room 
personnel following nitrous oxide and halothane exposure [22] has 
opened an ever since active area of research. The majority of studies 
published so far, almost without exception, have been addressed to 
examine the concomitant use of nitrous oxide and a halogenated gas, 
therefore only limited direct data is available about the currently used 
halogenated agents. 
In 1992 Saurel-Cubizolles and associates retrospectively studied, 
partially confirming the survey results from the 70s, that certain 
symptoms, such as headaches, dizziness, memory problems, fatigue 
were more frequent among staff of poorly ventilated operating theaters, 
especially among co-workers of pediatric surgical rooms [23]. In 1995 
Lucchini et al. registered the deterioration of reaction time at the end 
of the work week among staff of operating rooms who were exposed 
to enflurane and nitrous oxide, compared to the control group [24]. 
According to one of their latter study, the same staff performed worse 
on tests at the end of the work week when narcosis was maintained with 
gas compared to the total intravenous anesthesia [25]. A subsequent 
multicenter study suggests that no cognitive or psychomotor 
dysfunction were detected among operating room personnel when 
the exposure was held under the recommended level by applying 
appropriate protective measures [26]. 
Chronic exposure is assumed to affect not only the mental performance. 
A postural study of Vouriot et al. showed that central imbalance may 
develop as a result of prolonged work in operating rooms [27].
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Liver: It was reported that 25% of the patients had elevated level 
of liver enzymes after halothane anesthesia, but in most cases this 
was not accompanied by any clinical symptoms (type I. halothane 
hepatotoxicity). Halothane hepatitis is an antigen-antibody associated 
reaction (type II.) that occasionally causes massive cell necrosis. 
Genetically determined predisposition is likely to play a role in its 
pathogenesis (incidence 1:35000). The onset of halothane hepatitis 
has been reported in some cases as a result of recurring occupational 
exposure to sub-anesthetic concentrations of halothane [28,29]. A very 
limited number of case reports are available in the literature about 
isoflurane, enflurane, desflurane or sevoflurane induced hepatitis. 
The course of the diseases is familiar to the type II. Reaction but the 
exposure of these gases in sub-anesthetic concentration seems to be 
completely safe to the personnel. It has to be noted that in a recent 
prospective study of Casale and co-workers it was demonstrated that 
health workers exposed to anesthetic gases show higher levels of GOT, 
GPT, gamma GT and bilirubin levels compared to unexposed controls 
[30].
Genotoxicity: Initial studies reported contradictory results on the 
genotoxic effects [chromosome aberrations, sister chromatid exchange, 
micronucleus assay] of anesthetic gas exposure. Some examinations 
showed a dose dependent relationship between sister chromatid 
exchange, micronuclues formation in lymphocytes and gas exposure 
[31,32]. An increased incidence of sister chromatide exchange was 
reported due to low sevoflurane exposure (0.2 ppm) without the 
presence of nitrous oxide [33]. It is not entirely clear yet what are the 
health consequences of these phenomena, or if any other factors may 
play a role, like ionizing radiation, disinfectant aerosols or stress.
Carcinogenic effects: According to some early epidemiological 
surveys the incidence of leukemia, lymphoma and other malignant 
tumors is higher within the exposed population. Closer inspections on 
these studies show that these subjects were also exposed to various other 
factors, such as ionizing radiation. Considering the methodological 
weaknesses of the early researches and the reassuring results of animal 
studies, the risk of malignant diseases seems unlikely, however it 
cannot be ruled out entirely.
Reproductive toxicology: The first retrospective epidemiological 
studies from the 70s reported a correlation between the occupational 
exposure to anesthetic gases and spontaneous abortions and fetal 
malformations [34-38], and still serve as a basis for further studies 
and discussions nowadays. Later, the results of these surveys have 
been revised and criticized several times [39-41]. The shortcoming of 
the early studies is that the degree of exposure was undefined, and the 
results were only associated with the hours spent in operating rooms 
at best. 
A meta-analysis by Boivin and colleagues from 1997 has confirmed 
that exposure to high gas concentrations serve as a risk factor for 
abortions, if no air-suction system is available in the operating room 
[42]. But such outcomes were typical to the early studies. These results 
are in accordance with studies from recent years that came from the 
field of children anesthesia [43] and veterinary practice [44,45], where 
exposures are higher. Further fears related to the use of anesthetic gases, 
such as malformations, still births; decreased fertility has not been 
verified during the years. A study published in 2011 raises concerns, 
where data has been collected from clinical nurse specialists about 
their labour and possible congenital abnormalities for 10 years. Results 
showed that exposure to halogenated anesthetics can be associated with 
certain disorders, most commonly with abnormalities of the heart and 
epithelium [46]. Being aware of these results, caution and prevention 
are definitely justifiable. 
Pollution: It is little known about the impact of volatile anesthetics 
on the atmosphere, despite their potentially detrimental effect on global 
warming. According to Ryan and Nielsen each halogenated anesthetic 
has harmful impacts, especially desflurane [47]. The global-warming 
potentials of isoflurane, sevoflurane and desflurane (using CO2 as 
reference) are 1230, 1980 and 3714 [48]. 
Halogenated anesthetics may deplete the ozone layer as they 
reach the stratosphere, from this point of view, fluorine-containing 
gases such as auran and desflurane are less harmful than the chlorine-
containing ones like halothane, enflurane and isoflurane [49]. Although 
inhalational gases contribute to the ozone layer depleting factors with 
less than 0.03%, the cumulative effect of these gases should be kept in 
mind, since these compounds have a very long (4-21 years) elimination 
time [50]. Furthermore, the relative importance of the halogenated 
anesthetic’s impact on the ozone layer could increase in the future as 
the global utilization of chloro-fluoro-carbons (freons) reduces. 
How to Monitor the Degree of Halogenated Anesthetic 
Gas Exposure?
Monitoring the air is one of the most important equipment for 
the assessment of workplace contaminants. The main methods of 
detecting and measuring the atmospheric concentration of volatile 
anesthetics will be summarized below. Such data can provide adequate 
information for building design, working practices and administrative 
control systems, for the sake of maintain the lowest possible level of 
gases both in the operating rooms and in post-anesthesia care units.
Air samples should be collected every six months in order to assess 
the exposure of workers (according to the Occupational Safety and 
Health Administration) and the effectiveness of reference measurements 
should be verified as well. Monitoring only the most common agents is 
sufficient, since the possible corrective measures applied will reduce the 
amounts of other agents proportionally as well. There are three basic 
types of sample collection to assess work environment: personal, areal 
and source samples. Collection of personal samples is the best approach 
to measure the overall exposure of workers, because it represents gas 
concentrations of the worker’s breathing zone the best during the 
period of sample collection [4]. This is actually the most preferred 
method to measure workers’ average exposure per unit of time, both 
in operating theaters and in post-anesthetic care units. Where several 
people work together in the same job position, same place, shifts and 
the duration of exposure is also comparable, it is sufficient to gather 
information regarding exposure from only one representative person.
Areal data collection could be useful to determine the overall 
contamination of premises, or to compare the contamination of 
different spaces. Source samples could be useful to detect potential gas 
leakages, or to ascertain the malfunction of air-suction systems.
Sample collections can be cumulative and “real-time”. The latter 
one displays the direct concentration of anesthetics immediately by 
using a portable infrared spectrophotometer. The principle is that 
anesthetic gas molecules absorb infrared rays proportionally to their 
concentration. Since this method measures and provide feedback 
immediately, leakages and the effectiveness of controlling measures 
can be judged promptly.
In Germany and Switzerland Meier and his colleagues used a 
multi-gas monitor to measure halogenated anesthetics in the breathing 
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zone of anesthetists during 114 narcoses. The efficiency of the suction 
device was studied by detecting the leakage from the expiratory valve 
of the breathing circuit. The measurements were carried out with low 
fresh gas flow. The results show that the exposure of personnel could 
be reduced by 85 percent, if air-suction system was in operation [51]. 
Another illustrative example of monitoring is when the exposure 
of the staff showed a 50% decrease by replacing the air content of the 
operating room 10 times per hour. The importance and sensitivity 
of monitoring is emphasized by an observation, where a significant 
amount (exceeding the recommendations of National Institute for 
Occupational Safety and Health) of contamination was traceable even 
with cuffed endotracheal tubes.
Lee and his colleagues found that with standard ventilation the 
concentration of anesthetics exceed the threshold determined by the 
National Institute for Occupational Safety and Health. In these cases, 
the high values  could be explained with the suction of the endotracheal 
tube and the short accidental disconnection of the air-suction device 
[52].
In order to demonstrate how the anesthetic exposure depends on 
the quality of air exchanger and suction systems of the operating room, 
a few examples are summarized in Table 1 [53].
What are the Acceptable Upper Limits of Exposition in 
the European Union and in the United States? 
In the last decades simultaneously with the publication of studies 
on the harmful effects of sub-clinical doses of halogens, investigations 
have emerged to determine the highest permitted levels of exposure. The 
most appropriate unit of measurement in this case was the atmospheric 
concentration in parts per million (ppm) averaged to an 8 hours 
period. The NIOSH (National Institute for Occupational Safety and 
Health) is the most categorical if it comes to threshold determination. 
This limits the acceptable atmospheric concentration of all inhalational 
anesthetics to 2 ppm. However, no standards have been set based on 
unified consensus in the European Union to the present days. The 
following table illustrates the situation well since no limits have been 
determined in a significant number of the most widely used gases by 
this time (Table 2). The determined levels however have a considerable 
variation between countries. It should be noted that, unfortunately, 
the listed limits below have remained only recommendations so far, 
and none of the countries has integrated them in the category of safety 
conditions or requirements.
How to Reduce Air Contamination in Operating 
Theaters?
Air-suction system
 The air-suction device removes the air/gas mixture emitted 
through the overflow valves of the breathing circuit’s expiratory limb, 
thereby preventing the mixture to get into the surgical air space. The 
suction is ensured by the central vacuum, which ideally has a constant 
strength. The three most important components of the construction 
are the reservoir, the suction regulator and the negative and positive 
pressure valves. The reservoir can be a balloon that indicates increased 
pressure within the system by dilation, or a rigid container with ball-
valve, where the rise of the ball shows or could buffer excess pressure 
in the system. The air flow and air pressure is not constant within the 
air-suction device, both increases significantly during the expiratory 
phase. The reservoir is intended to buffer these pressure fluctuations. 
The pressure valve is activated if 1.) the central vacuum is too low 2.) 
the strength of suction is falsely under-regulated, and 3.) the suction 
is completely closed. The task of the pressure valve is to prevent the 
development of elevated pressure within the breathing circuit, thus 
avoid the incidence of barotrauma. The valve could be opened even 
at a pressure of 5 cm H2O. In this case the excess amount of gas is 
released into the operating room, resulting an increased exposure of 
the personnel.
Air circulation systems
 Although the suction system remains the most important means 
of reducing contamination, the air conditioning system is in the 
second place considering its importance. The fresh air enters at the 
level of the ceiling and reduces the concentrations of halogens in the 
operating room partly by dilution and partly by dissipation, and finally 
become complete by replacing the air itself. As it was pointed out in 
the monitoring section only the concomitant use of air circulation 
and suction systems could result a radical reduction in anesthetic gas 
concentrations of the operating room’s air. In post-anesthesia care units, 
where the exhalation of gases by patients causes the contamination, the 
air circulation system remains the only effective method to eliminate 
halogenated anesthetics. 
Air exchange equipment with recirculation has become popular 
nowadays due to economic considerations. Only a fraction of the 
removed air is emitted into the atmosphere, while the other fraction 
recirculates. If the same air would return that has left the room, the 
elimination of anesthetic gases would be ineffective. Therefore the 
system should be installed in a way that a safe distance is ensured 
between the operating theater and the spot where air is removed, thus 
the emitted air won’t recirculate. 
A system has an optimal capacity if it’s capable of replacing the 
operating theater’s air at least 15 times per hour. The direction of air 
flow is also important. The air inflow should take place close to the 
ceiling, while the outflow should befall at a lower level.
Air purification method
The concentration of anesthetic gas in the 
air collected from the anesthetist's breathing 
zone (ppm)
Without air conditioning unit N2O: 1000-3000
Halogenated anesthetics: 10-35
With air conditioning unit N2O: 200-500
Halogenated anesthetics: 2-5
With air-suction device, 
without air conditioning unit
N2O: 100-300
Halogenated anesthetics: 1-4
With both air suctioning and 
conditioning devices
N2O :10-35
Halogenated anesthetics: 0.2 to 0.5
Table 1: Relationship between how well equipped the operating rooms are and 
anesthetic gas exposure. (ppm=parts per million).
 Sevoflurane Isoflurane Enflurane Desflurane Halothane N2O
Austria - - - - 5 -
Denmark - - 2 - 5 100
France - - - - 2 -
Germany - - 20 - 5 100
England - 50 50 - 10 100
Italy - - - - - 100
Norway - 2 2 - 5 100
Sweden - 10 10 - 5 100
Switzerland - 10 10 - 5 100
United States 2 2 2 2 2 25
Table 2: The highest allowed anesthetic gas concentrations in operating rooms.
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Recirculation and Recycling of Halogenated Gases
Doyle and colleagues has demonstrated during a simulated 
narcosis that silica zeolite (Deltazite®) effectively absorbs isoflurane 
from the suction system [54]. The absorbed agent can be converted and 
reused with steam extraction and fractional distillation, in this way the 
emission of anesthetic gases into the atmosphere can be significantly 
reduced. 
Thomasson et al. placed a zeolite filter to the Y-connector, based 
on the principle of heat-moisture exchanger, thus the amount of gas 
use has been halved [55]. The development of the so-called anesthetic 
conserving device was based on this principle [56,57]. The system is 
closed to the halogenated anesthetics, but opened to the air-oxygen 
mixture. The gas is administered in liquid form through a perfusor 
into the device, which is located between the endotracheal tube and 
the Y-connector. The anesthetic gas is absorbed during exhalation and 
then released into the lung again during inhalation. In conclusion, 
the degree of gas consumption and atmosphere contamination could 
be reduced with 75%, therefore the method could be an effective 
alternative to low flow systems. The anesthetics conservation unit 
called Anaconda® was approved for the sedation of ICU patients at the 
end of the last decade [58].
How to Prevent Exposure of the Operating Personnel? 
Some practical aspects are highlighted below that can help to 
reduce the exposure of operating room personnel: 
• Check the valves and joints of the breathing circuit both with 
negative and positive pressure. Today’s modern anesthetic machines 
carry out this check-up automatically each time they are put into 
service as part of the mandatory inspection.
• Make sure that the room’s air exchange device works properly. 
• Make sure that the suction system is properly connected to the 
anesthetic machine and to the central vacuum line.
• Check the degree of leakage and the sensitivity of the suction 
system’s pressure valve.
• Refill the vaporizer with anesthetics only between two narcoses.
• Avoid excessive fresh gas flow.
• Disconnect the breathing circuit only when the anesthetic gas has 
already eliminated from it.
• When using uncuffed endotracheal tubes make sure that the tube 
is hermetically fill the airways, apply as effective tamponade as possible. 
• In case of child-anesthesia if the narcosis is induced with gas, or 
maintained with inhalational agents through mask it is advisable to use 
the so-called double mask instead of the traditional one.
In Conclusion
Neither animal nor human studies have provided any positive 
results so far about the severe direct organ toxicity of the halogeneted 
gases, if the exposure was chronic with low concentrations. 
In contrast, recently published studies on cognitive functions were 
unable to report reassuring results. It seems that long-term exposure 
with high concentrations has an influence on CNS functions such as 
concentration, memory, endurance, reaction time and coordination. 
Results from the recent decades show that workers exposed to 
anesthetics in high concentration are more prone to spontaneous 
abortion. At the same time it seems more and more certain that the 
currently used anesthetics have no mutagenic, carcinogenic or clinically 
significant genotoxic effects. Only the United States has set the level 
of acceptable atmospheric halogenated particles, which is 2 ppm on 
average as a maximum from each halogen. Meanwhile members of 
the European Union have not formed a unified view yet. Nevertheless, 
the parallel use of air-circulation and suction systems are turned out 
to be the most effective way to minimize exposure. If both systems 
work properly the exposure to anesthetic gases could be kept as low 
as possible. It is still need to be studied what the cumulative effects of 
the currently accepted, minimal pollution are on the staff of operating 
rooms on long-term.
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